Mekhail Adel 4
4 · Prestige Consumer Healthcare Inc. · Filed Nov 14, 2024
Insider Transaction Report
Form 4
Mekhail Adel
EVP, Marketing & Sales
Transactions
- Exercise/Conversion
Common Stock, par value $0.01 per share
2024-11-12$44.33/sh+5,565$246,696→ 27,428 total - Sale
Common Stock, par value $0.01 per share
2024-11-12$82.00/sh−9,063$743,166→ 18,365 total - Exercise/Conversion
Employee Stock Options (rights to buy)
2024-11-12−5,565→ 5,400 totalExercise: $44.33Exp: 2031-05-03→ Common Stock (5,565 underlying)
Footnotes (2)
- [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.92 to $82.02.
- [F2]The options vested in three equal installments of 3,655 shares on May 4, 2021, May 4, 2022 and May 4, 2023.